{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:21Z","timestamp":1792794261269,"version":"4.5.0"},"reference-count":206,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>A convincing deal of evidence supports the fact that severe psoriasis is associated with cardiovascular diseases. However, the precise underlying mechanisms linking psoriasis and cardiovascular diseases are not well defined. Psoriasis shares common pathophysiologic mechanisms with atherosclerosis and cardiovascular (CV) risk factors. In particular, polymorphism in the IL-23R and IL-23 genes, as well as other genes involved in lipid and fatty-acid metabolism, renin\u2013angiotensin system and endothelial function, have been described in patients with psoriasis and with cardiovascular risk factors. Moreover, systemic inflammation in patients with psoriasis, including elevated serum proinflammatory cytokines (e.g., TNF-\u03b1, IL-17, and IL-23) may contribute to an increased risk of atherosclerosis, hypertension, alteration of serum lipid composition, and insulin resistance. The nonlinear and intricate interplay among various factors, impacting the molecular pathways in different cell types, probably contributes to the development of psoriasis and cardiovascular disease (CVD). Future research should, therefore, aim to fully unravel shared and differential molecular pathways underpinning the association between psoriasis and CVD.<\/jats:p>","DOI":"10.3390\/ijms23169063","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T01:47:21Z","timestamp":1660528041000},"page":"9063","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-4733","authenticated-orcid":false,"given":"Stefano","family":"Piaserico","sequence":"first","affiliation":[{"name":"Unit of Dermatology, Department of Medicine, University of Padua, Via V. Gallucci 4, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Orlando","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, Department of Medicine, University of Padua, Via V. Gallucci 4, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Messina","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, Department of Medicine, University of Padua, Via V. Gallucci 4, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular Risk in Patients with Psoriasis: JACC Review Topic of the Week","volume":"77","author":"Garshick","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: Results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u201cpsoriatic march\u201d: A concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1038\/jid.2013.149","article-title":"Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis","volume":"133","author":"Samarasekera","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: A systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ejhf.113","article-title":"Psoriasis and risk of heart failure: A nationwide cohort study","volume":"16","author":"Khalid","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/09546634.2016.1255703","article-title":"Psoriasis increases risk of new-onset atrial fibrillation: A systematic review and meta-analysis of prospective observational studies","volume":"28","author":"Upala","year":"2017","journal-title":"J. Dermatol. Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archdermatol.2010.370","article-title":"Prevalence of the metabolic syndrome in psoriasis: Results from the National Health and Nutrition Examination Survey, 2003\u20132006","volume":"147","author":"Love","year":"2011","journal-title":"Arch Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","article-title":"Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: A systematic review and meta-analysis of observational studies","volume":"31","author":"Armstrong","year":"2013","journal-title":"J. Hypertens"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2340\/00015555-0510","article-title":"Psoriasis and dyslipidaemia: A population-based study","volume":"88","author":"Dreiher","year":"2008","journal-title":"Acta Derm. Venereol."},{"key":"ref_16","first-page":"WC01","article-title":"Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control Study","volume":"10","author":"Praveenkumar","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2011.06.035","article-title":"Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis","volume":"67","author":"Kimball","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/joim.13311","article-title":"Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: A multi-centre cohort study","volume":"290","author":"Tinggaard","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"775.e1","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable risk estimate of severe psoriasis on major cardiovascular events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the UK","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archdermatol.2009.94","article-title":"Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality","volume":"145","author":"Prodanovich","year":"2009","journal-title":"Arch Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2133.2011.10774.x","article-title":"Psoriasis and risk of nonfatal cardiovascular disease in, U.S. women: A cohort study","volume":"166","author":"Li","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_25","first-page":"E1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2017.06.028","article-title":"The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events","volume":"77","author":"Egeberg","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: A review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2019.02.015","article-title":"Genetics of Common, Complex Coronary Artery Disease","volume":"177","author":"Musunuru","year":"2019","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fphar.2020.00129","article-title":"Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges","volume":"11","author":"Ye","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/dna.2014.2573","article-title":"Functional polymorphisms in interleukin-23 receptor and susceptibility to coronary artery disease","volume":"33","author":"Zhang","year":"2014","journal-title":"DNA Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e22893","DOI":"10.1002\/jcla.22893","article-title":"The association between IL-17A and IL-23R polymorphisms and coronary artery disease risk in a Middle Eastern Chinese population","volume":"33","author":"Zhao","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/iji.12223","article-title":"Analysis of the association between IL-23R rs11209026 polymorphism and incidence of atherosclerosis","volume":"42","author":"Kave","year":"2015","journal-title":"Int. J. Immunogenet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat. Genet"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Chen, H., Poon, A., Yeung, C., Helms, C., Pons, J., Bowcock, A.M., Kwok, P.Y., and Liao, W. (2011). A genetic risk score combining ten psoriasis risk loci improves disease prediction. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019454"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2012.05.030","article-title":"Resequencing of the IL12B gene in psoriasis patients with the rs6887695\/rs3212227 risk genotypes","volume":"60","author":"Eiris","year":"2012","journal-title":"Cytokine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/dna.2019.4683","article-title":"The rs2066808 Polymorphism Located Near the IL-23A Gene Is Associated with Premature Coronary Artery Disease in Mexican Population (GEA Study)","volume":"38","author":"Fragoso","year":"2019","journal-title":"DNA Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","article-title":"The current landscape of psoriasis genetics in 2020","volume":"99","author":"Ogawa","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000502255","article-title":"A Meta-Analysis of the Relationship between Tumor Necrosis Factor-\u03b1 Polymorphisms and Psoriasis","volume":"237","author":"Wang","year":"2021","journal-title":"Dermatology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Huang, R., Zhao, S.-R., Li, Y., Liu, F., Gong, Y., Xing, J., and Xu, Z.S. (2020). Association of tumor necrosis factor-\u03b1 gene polymorphisms and coronary artery disease susceptibility: A systematic review and meta-analysis. BMC Med. Genet, 21.","DOI":"10.1186\/s12881-020-0952-2"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1046\/j.1523-1747.2000.00001.x","article-title":"Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism","volume":"114","author":"Kaluza","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rolski, F., and B\u0142yszczuk, P. (2020). Complexity of TNF-\u03b1 Signaling in Heart Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103267"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice","volume":"24","author":"Hovgaard","year":"2004","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2014.02.012","article-title":"TNF-\u03b1 promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: Crosstalk between NF-\u03baB and PPAR-\u03b3","volume":"72","author":"Zhang","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"41035","DOI":"10.1074\/jbc.M003464200","article-title":"Tumor necrosis factor-alpha -mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lee, J., Lee, S., Zhang, H., Hill, M.A., Zhang, C., and Park, Y. (2017). Interaction of IL-6 and TNF-\u03b1 contributes to endothelial dysfunction in type 2 diabetic mouse hearts. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187189"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: New prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.18632\/oncotarget.22260","article-title":"Serum levels of adipokines and cytokines in psoriasis patients: A systematic review and meta-analysis","volume":"9","author":"Bai","year":"2018","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators. Inflamm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2230.2009.03704.x","article-title":"Serum cytokines and growth factor levels in Japanese patients with psoriasis","volume":"35","author":"Takahashi","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1155\/2013\/856056","article-title":"Serum levels of selected Th17 and Th22 cytokines in psoriatic patients","volume":"35","author":"Kowal","year":"2013","journal-title":"Dis. Markers"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.npep.2012.11.001","article-title":"Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice","volume":"47","author":"Kakko","year":"2013","journal-title":"Neuropeptides"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.ATV.19.3.734","article-title":"The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.104.533463","article-title":"Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis","volume":"112","author":"Hauer","year":"2005","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1172\/JCI118650","article-title":"Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis","volume":"97","author":"Uyemura","year":"1996","journal-title":"J. Clin. Invest."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.biopha.2018.07.110","article-title":"The pleiotropic role of interleukin-17 in atherosclerosis","volume":"106","author":"Allam","year":"2018","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis: Subtle and contextual roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/STROKEAHA.114.006516","article-title":"Interleukin 23 levels are increased in carotid atherosclerosis: Possible role for the interleukin 23\/interleukin 17 axis","volume":"46","author":"Abbas","year":"2015","journal-title":"Stroke"},{"key":"ref_63","first-page":"3096","article-title":"IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","article-title":"Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability","volume":"106","author":"Erbel","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/ATVBAHA.111.227629","article-title":"Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice","volume":"31","author":"Madhur","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/jid.2012.112","article-title":"Chronic skin-specific inflammation promotes vascular inflammation and thrombosis","volume":"132","author":"Wang","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12944-017-0588-1","article-title":"IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein","volume":"16","year":"2017","journal-title":"Lipids. Health Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Hansson","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e23108","DOI":"10.1002\/jcla.23108","article-title":"Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents","volume":"34","author":"Sun","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2340\/00015555-0741","article-title":"Psoriasis and hypertension: A case-control study","volume":"90","author":"Cohen","year":"2010","journal-title":"Acta. Derm. Venereol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archdermatol.2009.48","article-title":"Psoriasis and the risk of diabetes and hypertension: A prospective study of US female nurses","volume":"145","author":"Qureshi","year":"2009","journal-title":"Arch. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamadermatol.2014.2094","article-title":"Effect of psoriasis severity on hypertension control: A population-based study in the United Kingdom","volume":"151","author":"Takeshita","year":"2015","journal-title":"JAMA Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5144\/0256-4947.2014.340","article-title":"Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism in psoriasis cases with hypertension","volume":"34","author":"Ogretmen","year":"2014","journal-title":"Ann. Saudi. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/aje\/kwj302","article-title":"Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: A HuGE review","volume":"164","author":"Casas","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/jid.2013.317","article-title":"Identification of a missense variant in LNPEP that confers psoriasis risk","volume":"134","author":"Cheng","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"48623","DOI":"10.1074\/jbc.C100512200","article-title":"Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase","volume":"276","author":"Albiston","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3945\/ajcn.2008.26382","article-title":"Relation between human vasopressin 1a gene variance, fat intake, and diabetes","volume":"89","author":"Leosdottir","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.09.034","article-title":"Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases","volume":"697","author":"Patel","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.10-2517","article-title":"Leucyl\/cystinyl aminopeptidase gene variants in septic shock","volume":"139","author":"Nakada","year":"2011","journal-title":"Chest"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Shibata, K., Kajiyama, H., Ino, K., Nawa, A., Nomura, S., Mizutani, S., and Kikkawa, F. (2007). P-LAP\/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-15"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Ramezani, M., Zavattaro, E., and Sadeghi, M. (2020). Angiotensin-converting enzyme gene insertion\/deletion polymorphism and susceptibility to psoriasis: A systematic review and meta-analysis. BMC Med. Genet., 21.","DOI":"10.1186\/s12881-019-0943-3"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1600-0625.2007.00620.x","article-title":"The angiotensin-converting enzyme insertion\/deletion and the endothelin -134 3A\/4A gene polymorphisms in patients with chronic plaque psoriasis","volume":"16","author":"Weger","year":"2007","journal-title":"Exp. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2007.08.005","article-title":"Assessment of insertion\/deletion polymorphism of the angiotensin converting enzyme gene in psoriasis","volume":"49","author":"Veletza","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/MJT.0b013e3181c6c0c2","article-title":"Psoriasis induced by losartan therapy: A case report and review of the literature","volume":"18","author":"Lamba","year":"2011","journal-title":"Am. J. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/exd.14159","article-title":"The role of the renin-angiotensin system in skin physiology and pathophysiology","volume":"29","author":"Silva","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1470320313478285","article-title":"The angiotensin-converting enzyme insertion\/deletion polymorphism and susceptibility to rheumatoid arthritis, vitiligo and psoriasis: A meta-analysis","volume":"16","author":"Song","year":"2015","journal-title":"J. Renin. Angiotensin. Aldosterone. Syst."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Purzycka-Bohdan, D., Kisielnicka, A., Bohdan, M., Szczerkowska-Dobosz, A., Sobalska-Kwapis, M., Nedoszytko, B., and Nowicki, R.J. (2021). Analysis of the Potential Genetic Links between Psoriasis and Cardiovascular Risk Factors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22169063"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2340\/00015555-0099","article-title":"Cardiovascular reactivity to experimental stress in psoriasis: A controlled investigation","volume":"86","author":"Mastrolonardo","year":"2006","journal-title":"Acta. Derm. Venereol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-4632.2011.05111.x","article-title":"The investigation of autonomic functions in patients with psoriasis","volume":"51","author":"Cicek","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00015559850135779","article-title":"Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity","volume":"78","author":"Bonifati","year":"1998","journal-title":"Acta. Derm. Venereol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Armstrong, A.W., Lin, S.W., Chambers, C.J., Sockolov, M.E., and Chin, D.L. (2011). Psoriasis and hypertension severity: Results from a case-control study. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018227"},{"key":"ref_100","first-page":"199","article-title":"High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients","volume":"40","author":"Ena","year":"1985","journal-title":"Acta. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/jid.2015.220","article-title":"Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis","volume":"135","author":"Li","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2016.05.036","article-title":"Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis","volume":"251","author":"Piaserico","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.RES.73.1.205","article-title":"Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life","volume":"73","author":"Yoshizumi","year":"1993","journal-title":"Circ. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"H398","DOI":"10.1152\/ajpheart.00691.2014","article-title":"Dual regulation of tumor necrosis factor-\u03b1 on myosin light chain phosphorylation in vascular smooth muscle","volume":"308","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-alpha in vascular dysfunction","volume":"116","author":"Zhang","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.107.102152","article-title":"Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy","volume":"51","author":"Sriramula","year":"2008","journal-title":"Hypertension"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jch.12612","article-title":"Elevated Serum Level of Interleukin 17 in a Population With Prehypertension","volume":"17","author":"Yao","year":"2015","journal-title":"J. Clin. Hypertens."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI80761","article-title":"Immune activation caused by vascular oxidation promotes fibrosis and hypertension","volume":"126","author":"Wu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2018.10.006","article-title":"Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis","volume":"29","author":"Huang","year":"2019","journal-title":"Cell Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jacbts.2016.07.009","article-title":"Inhibition of Interleukin 17-A but not Interleukin-17F Signaling Lowers Blood Pressure and Reduces End-organ Inflammation in Angiotensin II-induced Hypertension","volume":"1","author":"Saleh","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/BOR.0b013e3283031c99","article-title":"Psoriasis and metabolic disease: Epidemiology and pathophysiology","volume":"20","author":"Azfar","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/bjd.12473","article-title":"Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"169","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2017.10.050","article-title":"Psoriasis and the risk of diabetes: A prospective population-based cohort study","volume":"78","author":"Wan","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_116","first-page":"179","article-title":"Review of the Prevalence of Cardiovascular and Metabolic Comorbidities of Psoriasis","volume":"23","author":"Vebman","year":"2020","journal-title":"SKIN J. Cutan. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of Type 2 Diabetes\u2014Global Burden of Disease and Forecasted Trends","volume":"10","author":"Khan","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaad.2015.01.004","article-title":"Patients with psoriasis are insulin resistant","volume":"72","author":"Storgaard","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jmg.2007.053595","article-title":"Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease","volume":"45","author":"Wolf","year":"2008","journal-title":"J. Med. Genet"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/jid.2008.297","article-title":"Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22","volume":"129","author":"Li","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/exd.13393","article-title":"Identification of PTPN22, ST6GAL1 and JAZF1 as psoriasis risk genes demonstrates shared pathogenesis between psoriasis and diabetes","volume":"26","author":"Wang","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdermsci.2014.05.010","article-title":"Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus","volume":"75","author":"Queiro","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/bjd.17349","article-title":"Glucose metabolism in patients with psoriasis","volume":"180","author":"Friis","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1365-2133.2007.08190.x","article-title":"Psoriasis patients show signs of insulin resistance","volume":"157","author":"Boehncke","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: Time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1210\/endo.139.12.6337","article-title":"Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity","volume":"139","author":"Uysal","year":"1998","journal-title":"Endocrinology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/diab.46.9.1526","article-title":"Targeted disruption of the tumor necrosis factor-alpha gene: Metabolic consequences in obese and nonobese mice","volume":"46","author":"Ventre","year":"1997","journal-title":"Diabetes"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/jdv.12814","article-title":"Anti-TNF-\u03b1 therapy improves insulin sensitivity in non-diabetic patients with psoriasis: A 6-month prospective study","volume":"29","author":"Pina","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ijd.13420","article-title":"Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders","volume":"56","author":"Placek","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e24689","DOI":"10.5812\/jamm.24689","article-title":"Serum Interleukin 17 in Type 2 Diabetes Mellitus","volume":"2","author":"Zareian","year":"2014","journal-title":"J. Arch. Mil. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.imbio.2013.03.002","article-title":"Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels","volume":"218","author":"Jeremic","year":"2013","journal-title":"Immunobiology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.4049\/jimmunol.1001269","article-title":"IL-17 regulates adipogenesis, glucose homeostasis, and obesity","volume":"185","author":"Shen","year":"2010","journal-title":"J. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/HYPERTENSIONAHA.111.183178","article-title":"Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance","volume":"59","author":"Ohshima","year":"2012","journal-title":"Hypertension"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: From mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2016.06.049","article-title":"IL-17A synergistically enhances TNF\u03b1-induced IL-6 and CCL20 production in 3T3-L1 adipocytes","volume":"477","author":"Shinjo","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2013.06.317","article-title":"Adiponectin in inflammatory and immune-mediated diseases","volume":"64","author":"Fantuzzi","year":"2013","journal-title":"Cytokine"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2006.09.007","article-title":"Attenuation of leptin and insulin signaling by SOCS proteins","volume":"17","author":"Howard","year":"2006","journal-title":"Trends. Endocrinol. Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0625.2011.01402.x","article-title":"Leptin, adiponectin, visfatin and retinol-binding protein-4\u2013mediators of comorbidities in patients with psoriasis?","volume":"21","author":"Gerdes","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdermsci.2009.02.009","article-title":"Serum high molecular weight adiponectin levels are decreased in psoriasis patients","volume":"55","author":"Shibata","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2133.2008.08742.x","article-title":"Serum leptin levels, skin leptin and leptin receptor expression in psoriasis","volume":"159","author":"Cerman","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/ATVBAHA.107.147835","article-title":"Inflamed adipose tissue: A culprit underlying the metabolic syndrome and atherosclerosis","volume":"27","author":"Gustafson","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.jid.5700943","article-title":"PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor","volume":"128","author":"Romanowska","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/bjd.12101","article-title":"The association between psoriasis and dyslipidaemia: A systematic review","volume":"168","author":"Ma","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/art.38227","article-title":"Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis. Rheumatol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/jid.2012.366","article-title":"Association of cardiovascular and metabolic disease genes with psoriasis","volume":"133","author":"Lu","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Mallbris","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.arcmed.2012.10.009","article-title":"Apolipoprotein E gene polymorphism in psoriasis: A meta-analysis","volume":"44","author":"Han","year":"2013","journal-title":"Arch. Med. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2012.11170.x","article-title":"Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis","volume":"167","author":"Asefi","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/jid.2010.36","article-title":"Assessment of the psoriatic transcriptome in a large sample: Additional regulated genes and comparisons with in vitro models","volume":"130","author":"Gudjonsson","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1479-5876-11-194","article-title":"Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis","volume":"11","author":"Mehta","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Shih, C.-M., Chen, C.-C., Chu, C.-K., Wang, K.-H., Huang, C.-Y., and Lee, A.-W. (2020). The Roles of Lipoprotein in Psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030859"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00403-019-01986-x","article-title":"Antibodies towards high-density lipoprotein components in patients with psoriasis","volume":"312","author":"Batuca","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12929-017-0382-4","article-title":"Psoriasis-associated vascular disease: The role of HDL","volume":"24","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.atherosclerosis.2012.08.020","article-title":"HDL and adaptive immunity: A tale of lipid rafts","volume":"225","author":"Norata","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","article-title":"Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist","volume":"18","author":"Barrea","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2012.01.040","article-title":"Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control study","volume":"67","author":"Ruiz","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/1346-8138.12876","article-title":"Vitamin D3 levels and bone mineral density in patients with psoriasis and\/or psoriatic arthritis","volume":"42","author":"Kincse","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MAJ.0000000000000340","article-title":"Vitamin D serum level, disease activity and functional ability in different rheumatic patients","volume":"349","author":"Grazio","year":"2015","journal-title":"Am. J. Med. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2174\/138161211795428786","article-title":"The role of vitamin D in dyslipidemia and cardiovascular disease","volume":"17","author":"Zittermann","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/nutrit\/nuz037","article-title":"Effect of vitamin D supplementation on serum lipid profiles: A systematic review and meta-analysis","volume":"77","author":"Dibaba","year":"2019","journal-title":"Nutr. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3945\/ajcn.2008.27004","article-title":"Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers","volume":"89","author":"Zittermann","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/cs0870533","article-title":"Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroidism","volume":"87","author":"Lin","year":"1994","journal-title":"Clin. Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/039139889201501204","article-title":"Effects of 1,25 (OH)2D3 treatment on lipid levels in uremic hemodialysis patients","volume":"15","author":"Yeksan","year":"1992","journal-title":"Int. J. Artif. Organs."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2340\/00015555-2816","article-title":"Central Obesity in Children with Psoriasis","volume":"98","author":"Guidolin","year":"2018","journal-title":"Acta. Derm. Venereol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and Obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jamadermatol.2015.6262","article-title":"Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity","volume":"152","author":"Skov","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_178","first-page":"7304345","article-title":"The Influence of FTO Polymorphism rs9939609 on Obesity, Some Clinical Features, and Disturbance of Carbohydrate Metabolism in Patients with Psoriasis","volume":"2019","author":"Szepietowski","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_179","first-page":"69","article-title":"Gene polymorphisms of TNF-238G\/A, TNF-308G\/A, IL10-1082G\/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis","volume":"11","author":"Voiculescu","year":"2018","journal-title":"J. Med. Life"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-4632.2007.03324.x","article-title":"Lack of association between the G-2548A polymorphism of the leptin gene and psoriasis in a Turkish population","volume":"46","author":"Kara","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/13813455.2015.1024136","article-title":"Lack of association between leptin, leptin receptor, adiponectin gene polymorphisms and epicardial adipose tissue, abdominal visceral fat volume and atherosclerotic burden in psoriasis patients","volume":"121","author":"Torres","year":"2015","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/ijd.12306","article-title":"Omentin serum levels and omentin gene Val109Asp polymorphism in patients with psoriasis","volume":"53","author":"Turan","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00403-015-1549-z","article-title":"Omentin-1 plasma levels and omentin-1 expression are decreased in psoriatic lesions of psoriasis patients","volume":"307","author":"Zhang","year":"2015","journal-title":"Arch. Dermatol. Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"100064","DOI":"10.1016\/j.xjidi.2021.100064","article-title":"Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity","volume":"2","author":"Guo","year":"2022","journal-title":"JID Innov."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/1744666X.2016.1201423","article-title":"Crosstalk between skin inflammation and adipose tissue-derived products: Pathogenic evidence linking psoriasis to increased adiposity","volume":"12","author":"Chiricozzi","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12944-020-01391-8","article-title":"The role of leptin in selected skin diseases","volume":"19","author":"Dopytalska","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/exd.13149","article-title":"Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes","volume":"26","author":"Stjernholm","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000481882","article-title":"Serum Leptin, Resistin, and Adiponectin Concentrations in Psoriasis: A Meta-Analysis of Observational Studies","volume":"233","author":"Kyriakou","year":"2017","journal-title":"Dermatology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1038\/ncomms8687","article-title":"Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from \u03b3\u03b4-T cells","volume":"6","author":"Shibata","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2008.08655.x","article-title":"Obesity in psoriasis: Leptin and resistin as mediators of cutaneous inflammation","volume":"159","author":"Johnston","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5021\/ad.2016.28.1.74","article-title":"Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris","volume":"28","author":"Coban","year":"2016","journal-title":"Ann. Dermatol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"3000605211002381","DOI":"10.1177\/03000605211002381","article-title":"Association between serum visfatin levels and psoriasis and their correlation with disease severity: A meta-analysis","volume":"49","author":"Zou","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: A link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J. Cardiol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/hc0702.104279","article-title":"Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year","volume":"105","author":"Ziccardi","year":"2002","journal-title":"Circulation"},{"key":"ref_195","unstructured":"McManus, L.M. (2014). Normal Adipose Tissue Biology: Adipocytokines and Inflammation. Mitchell RNBT-P of, H.D., Academic Press."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","article-title":"The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase","volume":"95","author":"Kern","year":"1995","journal-title":"J. Clin. Invest."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","article-title":"Pro-inflammatory cytokines: The link between obesity and osteoarthritis","volume":"44","author":"Wang","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/eji.200838893","article-title":"Obesity predisposes to Th17 bias","volume":"39","author":"Winer","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Polak, K., Bergler-Czop, B., Szczepanek, M., Wojciechowska, K., Fr\u0105tczak, A., and Kiss, N. (2021). Psoriasis and Gut Microbiome-Current State of Art. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094529"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/exd.13786","article-title":"Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients","volume":"27","author":"Chen","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/PTT.S342911","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies","volume":"11","author":"Balak","year":"2021","journal-title":"Psoriasis"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep4.1519","article-title":"Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis","volume":"4","author":"Young","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"102429","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Puig","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17\/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver","volume":"196","author":"Rau","year":"2016","journal-title":"J. Immunol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/16\/9063\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:08:15Z","timestamp":1760141295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/16\/9063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":206,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23169063"],"URL":"https:\/\/doi.org\/10.3390\/ijms23169063","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]}}}